Suppr超能文献

β-肾上腺素能阻滞剂对视网膜循环的影响

[Effects of beta-adrenergic blockers on retinal circulation].

作者信息

Ishikawa Y, Kiuchi Y, Takamatsu M, Mishima H

机构信息

Department of Ophthalmology, Hiroshima University School of Medicine, Hiroshima-ken, Japan.

出版信息

Nippon Ganka Gakkai Zasshi. 1996 Oct;100(10):798-802.

PMID:8937104
Abstract

We evaluated the effects of 0.5% betaxolol hydrochloride and 0.5% timolol maleate on retinal blood flow. We measured the diameter of the retinal artery (Da) and vein (Dv), and retinal venous blood flow rate (V) in 8 healthy young volunteers by laser speckle velocimetry before and after the application of betaxolol or timolol topically to both eyes daily for one week. There were no any significant changes. Da before and after the application of betaxolol was 114.2 +/- 6.3 (mean +/- standard deviation) microns and 115.6 +/- 6.7 microns and before and after the application of timolol, 117.5 +/- 12.7 microns and 101.3 +/- 9.5 microns. Dv before and after the application of betaxolol was 149.5 +/- 11.1 microns and 148.4 +/- 13.3 microns, and before and after the application of timolol 148.5 +/- 9.2 microns and 146.2 +/- 10.3 microns. V before and after the application of timolol was 12.3 +/- 2.6 mm/s and 12.6 +/- 2.4 mm/s, and before and after the application of betaxolol, 11.6 +/- 1.5 mm/s and 11.4 +/- 2.1 mm/s. Thus one-week application of the beta-blockers, betaxolol and timolol did not change the retinal arterial or venous blood flow.

摘要

我们评估了0.5%盐酸倍他洛尔和0.5%马来酸噻吗洛尔对视网膜血流的影响。我们通过激光散斑测速法,在8名健康年轻志愿者双眼每日局部应用倍他洛尔或噻吗洛尔一周前后,测量了视网膜动脉直径(Da)、静脉直径(Dv)和视网膜静脉血流速度(V)。未发现任何显著变化。应用倍他洛尔前后的Da分别为114.2±6.3(均值±标准差)微米和115.6±6.7微米,应用噻吗洛尔前后分别为117.5±12.7微米和101.3±9.5微米。应用倍他洛尔前后的Dv分别为149.5±11.1微米和148.4±13.3微米,应用噻吗洛尔前后分别为148.5±9.2微米和146.2±10.3微米。应用噻吗洛尔前后的V分别为12.3±2.6毫米/秒和12.6±2.4毫米/秒,应用倍他洛尔前后分别为11.6±1.5毫米/秒和11.4±2.1毫米/秒。因此,β受体阻滞剂倍他洛尔和噻吗洛尔一周的应用并未改变视网膜动脉或静脉血流。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验